Vishnu R. Kannabiran

Early Tumor Progression Associated with Enhanced EGFR Signaling with Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer

Athanassios Argiris, Austin G. Duffy, Shivaani Kummar et al. · Clinical Cancer Research · 2011 · 56 citations · Full text

MEK Inhibitor PD-0325901 Overcomes Resistance to CK2 Inhibitor CX-4945 and Exhibits Anti-Tumor Activity in Head and Neck Cancer

Yansong Bian, Jiawei Han, Vishnu R. Kannabiran et al. · International Journal of Biological Sciences · 2015 · 43 citations · Full text

The color of cancer: Margin guidance for oral cancer resection using elastic scattering spectroscopy

Gregory A. Grillone, Zimmern Wang, Gintas P. Krisciunas et al. · The Laryngoscope · 2017 · 30 citations · Full text

HSP90 Inhibitor SNX5422/ 2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma

Jay Friedman, Stephanie C. Wise, Michael Y. Hu et al. · Translational Oncology · 2013 · 25 citations · Full text

Transcription Factor Network, Immunotherapeutics, Cancer Biology +22

The calcineurin inhibitor RCAN1 is involved in cultured macrophage and in vivo immune response

Dipti L. Bhoiwala, Vishnu R. Kannabiran, Shazneen F. Hushmendy et al. · FEMS Immunology & Medical Microbiology · 2010 · 10 citations